Lv7
3370 积分 2020-12-13 加入
一个2021年了还在研究SCR和TVS的LOSER
Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Antitumor Activity of the Cyclin-Dependent Kinase-9 (CDK9) Inhibitor AZD4573 in Relapsed/Refractory Hematological Malignancies: A Phase 1 First-in-Human Study
28天前
已完结
沟槽栅SiC JFET器件结构设计
2个月前
已完结
超高压JFET器件电参数的合理实现
2个月前
已完结
确定JFET特性的简单电路
2个月前
已完结
结型场效应晶体管JFET
2个月前
已关闭
一种恒流JFET器件及其制造方法
2个月前
已完结
Chemotherapy-induced peripheral neuropathy and rehabilitation: A review
2个月前
已完结
Safety, tolerability, pharmacokinetics, and pharmacodynamics of PF-06650833, a selective interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitor, in single and multiple ascending dose randomized phase 1 studies in healthy subjects
2个月前
已关闭
临床生化指标在新药临床前研究中的毒理学意义
2个月前
已完结
皖公网安备34019202002308
